Biologics Archives - Page 16 of 88 - Becker’s Spine Review

Biden administration launches program focused on orthobiologics

The Biden administration launched a program under the Advanced Research Projects Agency for Health focused on orthopedic tissue regeneration.

5 developments in orthobiologics

Here are five developments in orthobiologics to know since April 1:

Royal Biologics launches new bone graft substitute

Royal Biologics launched its Bio-Reign 3D bone graft substitute, the company said May 23.

Study supports efficacy of StemSpine procedure

Creative Medical Technology Holdings' StemSpine procedure was found to be effective in treating chronic lower back pain, according to a pilot study.

Bioventus sells wound care segment

Bioventus sold its wound care segment to LifeNet Health, according to a May 10 news release.

1,000 patients treated with OssDesign spinal bone graft

OssDesign's Catalyst nanosynthetic bone graft has been used in 1,000 patients, the medtech company said May 9.

Bioventus CEO steps down

Bioventus' CEO Ken Reali left his post on April 4.

University of Colorado Medicine opens regenerative orthopedic center

Aurora-based University of Colorado Medicine opened the CU Medicine Regenerative Medicine, Hand and Spine Center in Englewood.

5 orthobiologics updates in Q1

Here are five updates in orthobiologics and regenerative medicine to know from the first quarter of 2023:

Minimally invasive cellular allograft system cleared for use in trauma procedures

The world's first viable bone matrix that provides lineage-committed bone cells, LifeNet Health's ViviGen MIS, is now available for use in trauma procedures.